patients

$10 Billion In Annual U.S. DTC Healthcare Advertising Indicates Merging Of Patient And Consumer
$10 Billion In Annual U.S. DTC Healthcare Advertising Indicates Merging Of Patient And Consumer
Forbes
patients
consumers
DTC advertising
Flag link:
Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials
Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials
Endpoints
Chimerix
patients
clinical trials
Brincidofovir
Flag link:
Should Patients Have a Say in Medical Device Regulatory Matters?
Should Patients Have a Say in Medical Device Regulatory Matters?
Medical Devices and Diagnostics Industry
FDA
devices
regulatory
patients
Flag link:
Patient access pitfalls, regulatory inconsistencies hamper tissue agnostic drugs
Patient access pitfalls, regulatory inconsistencies hamper tissue agnostic drugs
BioCentury
FDA
ASCO
oncology
drug development
patients
clinical trials
tissue-agnostic drugs
Flag link:
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
Forbes
diabetes
value-based care
patients
startups
Flag link:
Zoll reveals data breach during email server migration
Zoll reveals data breach during email server migration
Mass Device
ZOLL Medical
cybersecurity
devices
patients
Flag link:
Survey shows mixed views from patients on smart pills
Survey shows mixed views from patients on smart pills
Pharmaforum
smart pills
drug delivery
patients
Flag link:
Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage
Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage
Stat
Canada
patients
Flag link:
Rare Disease Day: How the patient voice can tear down barriers
Rare Disease Day: How the patient voice can tear down barriers
Pharmaforum
patients
Rare Diseases
Flag link:
JPM, Berkshire, Amazon venture to test how best to shake up benefits scheme
JPM, Berkshire, Amazon venture to test how best to shake up benefits scheme
BioCentury
ABC
Amazon
Berkshire Hathaway
JPMorgan
patients
Flag link:
What Will Keep Medtech up at Night in 2019?
What Will Keep Medtech up at Night in 2019?
Medical Devices and Diagnostics Industry
devices
taxes
cybersecurity
reimbursement
trade
technology
regulatory
patients
physicians
Flag link:
‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress
‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress
Stat
cystic fibrosis
drug development
patients
Flag link:
No, A.I. Won't Worsen Health Disparities But It May Safeguard the Doctor-Patient Relationship
No, A.I. Won't Worsen Health Disparities But It May Safeguard the Doctor-Patient Relationship
Forbes
artificial intelligence
physicians
patients
Flag link:
A year after Trump touted ‘right to try,’ patients still aren’t getting treatment
A year after Trump touted ‘right to try,’ patients still aren’t getting treatment
Stat
right-to-try laws
patients
Flag link:
Cystic fibrosis patients lobby Vertex to drop drug prices
Cystic fibrosis patients lobby Vertex to drop drug prices
Pharmaforum
Vertex Pharmaceuticals
cystic fibrosis
drug pricing
patients
Flag link:
Bayer to increase patient access to specialty drugs with ZappRx digital platform
Bayer to increase patient access to specialty drugs with ZappRx digital platform
BioCentury
Bayer
ZappRx
patients
pulmonary hypertension
Relapsing Remitting Multiple Sclerosis
Adempas riociguat
IFNβ-1b Betaferon
Flag link:
Diabetes tech execs talk patient-centric design, device development & trust
Diabetes tech execs talk patient-centric design, device development & trust
Mass Device
diabetes
patients
devices
clinical trials
Flag link:
'Bad drug' lawsuit ads hurt doc-patient relationships and need regulation, says industry coalition
'Bad drug' lawsuit ads hurt doc-patient relationships and need regulation, says industry coalition
Fierce Pharma
patients
physicians
drug safety
Flag link:
Novartis, still struggling with Kymriah manufacturing, is providing some out-of-spec doses to patients who ask
Novartis, still struggling with Kymriah manufacturing, is providing some out-of-spec doses to patients who ask
Fierce Pharma
Novartis
patients
CAR-T
Kymriah
drug manufacturing
Flag link:
2018 in review: How patient centricity led to new drugs that tackle unmet need
2018 in review: How patient centricity led to new drugs that tackle unmet need
Pharmaforum
patients
drug development
Sunovion
Sangamo
Amryt Pharma
Flag link:

Pages